Current Perspectives, Practices, and Barriers Faced by Community Pharmacists Regarding Pharmaceutical Care Services for Diabetes Mellitus in the United Arab Emirates

References

• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;37:S81–S90. doi:10.2337/dc14-S081
   PubMed Web of Science ®Google Scholar
• World Health Organization. The top 10 causes of death; 2020. Available from: https://www.who.int/en/newsroom/fact-sheets/detail/the-top-10-causes-of-death. Accessed January 16, 2023.
   Google Scholar
• Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabet Res Clin Pract. 2011;94(3):311–321. doi:10.1016/j.diabres.2011.10.029
   PubMed Web of Science ®Google Scholar
• Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabet Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels, Belgium: International Diabetes Federation; 2020:7–44.
   Google Scholar
• Sulaiman N, Albadawi S, Abusnana S, Mairghani M, Hussein A, Al Awadi F. High prevalence of diabetes among migrants in the United Arab Emirates using a cross-sectional survey. Sci Rep. 2018;8(1):6862. doi:10.1038/s41598-018-24312-3
   PubMedGoogle Scholar
• Sulaiman N, Mahmoud I, Hussein A, Elbadawi S, Abusnana S, Zimmet P. Diabetes risk score in the United Arab Emirates: a screening tool for the early detection of type 2 diabetes mellitus. BMJ Open Dib Res Care. 2018;6:e000489. doi:10.1136/bmjdrc-2017-000489
   PubMed Web of Science ®Google Scholar
• Alawadi F, Hassanein M, Sulaiman E, et al. The prevalence of diabetes and prediabetes among population: finding from Dubai household survey 2014. DDE. 2017;2017:1.
   Google Scholar
• Immons RK, Griffin SJ, Witte DR, Borch- Johnsen K, Lauritzen T, Sandb KA. Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults. Diabetologia. 2017;60(11):2183–2191. doi:10.1007/s00125-017-4323-2
   PubMed Web of Science ®Google Scholar
• Dall TM, Yang W, Halder P, et al. The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care. 2014;37(12):3172–3179. doi:10.2337/dc14-1036
   PubMed Web of Science ®Google Scholar
• Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care. 1993;16(4):642–652. doi:10.2337/diacare.16.4.642
   PubMed Web of Science ®Google Scholar
• Kilpi F, Webber L, Musaigner A, et al. Alarming predictions for obesity and non-communicable diseases in the Middle East. Public Health Nutr. 2014;17:1078–1086. doi:10.1017/S1368980013000840
   PubMed Web of Science ®Google Scholar
• Al-Shudifat AE, Al-Shdaifat A, Al-Abdouh AA, et al. Diabetes risk score in a young student population in jordan: a cross-sectional study. J Diabetes Res. 2017;2017:8290710. doi:10.1155/2017/8290710
   PubMed Web of Science ®Google Scholar
• Venkartesan R, Devi AS, Parasuraman S, Sriram S. Role of community pharmacist in improving knowledge and glycemic control of type 2 diabetes. Perspect Clin Res. 2012;3(1):26–31. doi:10.4103/2229-3485.92304
   PubMedGoogle Scholar
• O’Loughlin J, Masson P, Déry V, Fagnan D. The role of community pharmacists in health education and disease prevention: a survey of their interests and needs in relation to cardiovascular disease. Prev Med. 1999;28(3):324–333. doi:10.1006/pmed.1998.0436
   PubMed Web of Science ®Google Scholar
• Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency in patient compliance. Diabetes Care. 1997;20:1512–1517. doi:10.2337/diacare.20.10.1512
   PubMed Web of Science ®Google Scholar
• Echouffo-Tcheugui JB, Mayige M, Ogbera AO, Sobngwi E, Kengne AP. Screening for hyperglycemia in the developing world: rationale, challenges and opportunities. Diabet Res Clin Pract. 2012;98:199–208. doi:10.1016/j.diabres.2012.08.003
   PubMed Web of Science ®Google Scholar
• Hagstrom B, Mattsson B. Screening for diabetes in general practice. Opportunistic screening for diabetes in general practice is better than nothing. BMJ. 2002;324:425–426. doi:10.1136/bmj.324.7334.425/a
   PubMedGoogle Scholar
• Chua SS, Ramachandran CD, Paraidathathu TT. Response of community pharmacists to the presentation of back pain: a simulated patient study. Int J Pharm Pract. 2006;14:171–178. doi:10.1211/ijpp.14.3.0003
   Google Scholar
• Jairoun AA, Al-Hemyari SS, Shahwan M, et al. Access to community pharmacy services for people with disabilities: barriers, challenges, and opportunities. Res Social Administrative Pharm. 2022;18(5):2711–2713. doi:10.1016/j.sapharm.2022.01.009
   PubMed Web of Science ®Google Scholar
• Jairoun AA, Al-Hemyari SS, Shahwan M, et al. Top unresolved ethical challenges and dilemmas faced by community pharmacists in providing pharmaceutical care: drawing the line between ethical challenges and the quality of the pharmaceutical care. Res Soc Admin Pharm. 2022;2022:1551–7411.
   Google Scholar
• Jairoun AA, Al-Hemyari SS, Jairoun M, El-Dahiyat F, Al-Ani M, Habeb M. Hidden factors in community pharmacy related to medication safety risks: pushing patient safety to breaking point. Res Soc Admin Pharm. 2021;2021:1551–7411.
   Google Scholar
• Anderson C, Blenkinsopp A, Armstrong M. The contribution of community pharmacy to improving the public’s health: summary report of the literature review 1990–2007. Available from: http://eprints.nottingham.ac.uk/1576/. Accessed March 11, 2023.
   Google Scholar
• Dent LA, Harris KJ, Noonan CW. Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother. 2009;43:194–201. doi:10.1345/aph.1L556
   PubMed Web of Science ®Google Scholar
• Mangum SA, Kraenow KR, Narducci WA. Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects. J Am Pharm Assoc. 2003;43:50–55. doi:10.1331/10865800360467042
   Google Scholar
• Hess KM, Dai CW, Garner B, Law AV. Measuring outcomes of a pharmacist-run travel health clinic located in an independent community pharmacy. J Am Pharm Assoc. 2010;50:174–180. doi:10.1331/JAPhA.2010.09204
   Google Scholar
• Mehuys E, Van Bortel L, De Bolle L, et al. Effectiveness of a community pharmacist intervention in diabetes care: a randomized control trial. J Clin Pharm Ther. 2011;36(5):602–613. doi:10.1111/j.1365-2710.2010.01218.x
   PubMed Web of Science ®Google Scholar
• World Health Organization 2002. Core health indicators – united Arab Emirates; 2022. Available from: http://www.who.int/whosis/database/core/core_select_process.cfm?country=are&indicators=healthpersonnel. Accessed May 06, 2024.
   Google Scholar
• Ministry of Health – UAE 2003. Guidelines and Minimum Standards for Good Pharmacy Practice in UAE Pharmacies; 2022. Available from: http://www.cpdpharma.ae/index.php?option=com_phocadownload&view=category&download=76:ministry-of-healthguideline-and-minimum-standards-for-goodpharmacy-practice-gpp-version-1-2003&id=2:mohpolicies-and-circulars&Itemid=78. Accessed May 06, 2024.
   Google Scholar
• Ministry of Health – UAE 2011. Drug registration and control administration statistics 2010–2011; 2011.
   Google Scholar
• Awad A, Al-Ebrahim S, Abahussain E. Pharmaceutical care services in hospitals of Kuwait. J Pharm Pharm Sci. 2006;9(2):149–157.
   PubMed Web of Science ®Google Scholar
• Sanah H, Hana S, Colin C, Kay S, David K. Community pharmacy in the United Arab Emirates: characteristics and workforce issues. Intl J Pharm Prac. 2011;19:392–399. doi:10.1111/j.2042-7174.2011.00134.x
   PubMedGoogle Scholar
• Hasan S, Sulieman H, Stewart K, Chapman CB, Hasan MY, Kong DC. Assessing patient satisfaction with community pharmacy in the UAE using a newly-validated tool. Res Social Adm Pharm. 2013;9(6):841–850. doi:10.1016/j.sapharm.2012.10.002
   PubMed Web of Science ®Google Scholar
• Hasan S, Sulieman H, Chapman CB, Stewart K, Kong DC. Community pharmacy services in the United Arab Emirates. Int J Pharm Pract. 2012;20(4):218–225. doi:10.1111/j.2042-7174.2011.00182.x
   PubMedGoogle Scholar
• Majd D. Pharmacy in the United Arab Emirates. South Med Rev. 2009;2(1):15.
   PubMedGoogle Scholar
• Sadek MM, Elnour AA, Al Kalbani NM, et al. Community pharmacy and the extended community pharmacist practice roles: the UAE experiences. Saudi Pharm J. 2016;24(5):563–570. doi:10.1016/j.jsps.2015.03.023
   PubMed Web of Science ®Google Scholar
• El Hajj MS, Al-saeed HS, Khaja M. Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care. Int J Clin Pharm. 2016;38(2):330–343. doi:10.1007/s11096-016-0246-0
   PubMed Web of Science ®Google Scholar
• Abdi AM, Zarouri AT, Saloumi L, Basgut B. North Cyprus pharmacist’s cognition and practice of pharmaceutical care. J Pharm Res Int. 2018;21:1–9. doi:10.9734/JPRI/2018/39051
   Web of Science ®Google Scholar
• Alzubaidi H, Saidawi W, Mc NK. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates. Int J Clin Pharm. 2018;40(5):1106–1115. doi:10.1007/s11096-018-0662-4
   PubMed Web of Science ®Google Scholar
• Gerber RA, Liu G, Mccombs JS. Impact of pharmacist consultations provided to patients with diabetes on healthcare costs in a health maintenance organization. Am J Manag Care. 1998;4(7):991–1000.
   PubMed Web of Science ®Google Scholar
• The R, Chen T, Krass I. Consumer perspectives of pharmacist delivered health promotion and screening services. Int J Pharm Pract. 2001;9:261–267.
   Google Scholar
• Armour CL, Taylor SJ, Hourihan F, Smith C, Krass I. Implementation and evaluation of Australian pharmacists’ diabetes care services. Medscape; 2004. Available from: http://www.medscape.com/viewarticle/487477. Accessed February 14, 2023.
   Google Scholar
• Reddy PV, Kapoor KV. Impact of patient counseling on knowledge of diabetes mellitus and its management. Ind J Hospital Pharm. 2005;42:96–99.
   Google Scholar
• Dhippayom T, Fuangchan A, Tunpichart S, Chaiyakunapruk N. Opportunistic screening and health promotion for type 2 diabetes: an expanding public health role for the community pharmacist. J Public Health. 2013;35:262–269. doi:10.1093/pubmed/fds078
   Web of Science ®Google Scholar
• Shrestha M, Maharjan R, Prajapati A, Ghimire S, Shrestha N, Banstola A. Assessment of knowledge and practice of community pharmacy personnel on diabetes mellitus management in Kathmandu district: a cross sectional descriptive study. J Diabetes Metab Disord. 2015;14:1–6. doi:10.1186/s40200-015-0205-7
   PubMedGoogle Scholar
• Upadhyay DK, Alurkar VM, Mishra P, Palaian S. Evaluation of knowledge, attitude and practice of newly diagnosed diabetes patients-a baseline study from Nepal. Internat J Pharm Teach Pract. 2012;3(2):1–8.
   Google Scholar
• Qamar M, Iqubal RR, Ahmad S, Shaikh FA, Ismail NE. Awareness of diabetes mellitus among general public in Shah Alam, Malaysia: a cross-sectional study. Asian J Pharm Clin Res. 2017;10(9):192–196. doi:10.22159/ajpcr.2017.v10i9.17747
   Google Scholar
• Ramesh R, Kumar SV, Gopinath S, Gavaskar B, Gandhiji G. Diabetic knowledge of rural community and drug utilization pattern in a tertiary care hospital. Int J Pharm Life Sci. 2011;2:1.
   Google Scholar
• Lawshe C. A quantitative approach to content validity. Pers Psychol. 1975;28:563–575. doi:10.1111/j.1744-6570.1975.tb01393.x
   Web of Science ®Google Scholar
• Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health. 2007;30(4):459–467. doi:10.1002/nur.20199
   PubMed Web of Science ®Google Scholar
• Alhaiti AH, Alotaibi AR, Jones LK, DaCosta C, Lenon GB. Psychometric evaluation of the revised Michigan diabetes knowledge test (V. 2016) in Arabic: translation and validation. J Diabet Res. 2016;2016:1–7. doi:10.1155/2016/9643714
   Web of Science ®Google Scholar
• Fitzgerald JT, Funnell MM, Hess GE, et al. The reliability and validity of a brief diabetes knowledge test. Diabetes Care. 1998;21(5):706–710. doi:10.2337/diacare.21.5.706
   PubMed Web of Science ®Google Scholar
• Emirates News Agency. UAE has over 2000 private pharmacies, 4000 professionals. 2010 Available from: http://wam.ae/en/details/1395228626943. Accessed May 06, 2024.
   Google Scholar
• McMurray SD, Johnson G, Davis S, Mc Dougall K. Diabetes education and care management significantly improve patient outcomes in the dialysis unit. Am J Kidney Disease. 2002;40:566–575. doi:10.1053/ajkd.2002.34915
   PubMed Web of Science ®Google Scholar
• Erku DA, Belachew SA, Mekuria AB, et al. The role of community pharmacists in patient counseling and health education: a survey of their knowledge and level of involvement in relation to type 2 diabetes mellitus. Integrat Pharm Res Pract. 2017;19:137–143. doi:10.2147/IPRP.S140777
   Google Scholar
• Eades CE, Ferguson JS, O’Carroll RE. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health. 2011;11:582. doi:10.1186/1471-2458-11-582
   PubMed Web of Science ®Google Scholar
• Bisheya AF, El-Mijbri SB, Beshyah SA, Sherif I. Community pharmacists’ knowledge, attitude and practice towards diabetes care in Tripoli, Libya. Ibnosina J Med Biomed Sci. 2011;3(3):89–95. doi:10.4103/1947-489X.210877
   Google Scholar
• Basri MA, Yousef SE, ElHajj M. Diabetes Mellitus Care in the State of Qatar: A Survey of Pharmacists’ Activities, Attitudes and Knowledge. Qatar: Qatar University; 2013.
   Google Scholar
• Chen HY, Lee TY, Huang WT, Chang CJ, Chen CM. The short-term impact of a continuing education program on pharmacists’ knowledge and attitudes toward diabetes. Am J Pharm Educ. 2004;68(5):1–5. doi:10.5688/aj6805121
   Web of Science ®Google Scholar
• Snella KA, Canales AE, Irons BK, et al. Pharmacy- and community based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc. 2006;46:370–377. doi:10.1331/154434506777069598
   Google Scholar
• Laliberté MC, Perreault S, Damestoy N, Lalonde L. Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada. BMC Public Health. 2012;12:192. doi:10.1186/1471-2458-12-192
   PubMed Web of Science ®Google Scholar
• Abduelkarem AR, Sackville MA, Morgan RM, Sackville MP, Hildreth AJ. Views and practices of community pharmacists regarding services for people with type 2 diabetes. Int J Pharm Pract. 2003;11:161–168. doi:10.1211/0022357021990
   Google Scholar
• Kotecki JE, Elanjian SI, Torabi MR. Health promotion beliefs and practices among pharmacists. J Am Pharm Assoc. 2000;40(6):773–779. doi:10.1016/S1086-5802(16)31124-X
   Google Scholar